Annual Secretarial Compliance Report for the Financial Year ended March 31, 2025.
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, to both NSE and BSE. The report was issued by M/s. Vishwas Sharma & Associates, a Practicing Company Secretary (C.P. No. 16942). This submission is made as required under Regulation 24(A) of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The letter was signed by Trusha Shah, the Company's Secretary and Compliance Officer, on May 17, 2025. No specific compliance deviations or observations are mentioned in this cover letter.
This is a routine annual regulatory filing required by SEBI and does not indicate any material business event or change. No immediate impact on shareholders or stock price is expected, as it simply fulfills a yearly compliance obligation.